43 U.S. Senators Vow to Stop Passage of H.R. 620: The ADA Education and Reform Act of 2017
Look for Your April Issue of The Physiatrist
CMS Updates Rates and Expands Opioid Policies Under Medicare Advantage and Part D
Open Payments Review Open Now Through May 15
Updated List of DMEPOS HCPCS Codes Potentially Subject to Pre-authorization
CMS Extends the MIPS 2017 Data Submission Deadline from March 31 to April 3 at 8 PM EDT
AAPM&R Members in the News: March 2018
AAPM&R Receives ACCME Accreditation with Commendation
AAPM&R Submits Joint Response to HHS on Drug Pricing Proposals
March 26, 2018 Coding Q&A
AAPM&R and ACRM Form a Strategic Alliance to Increase Awareness of the Value of Rehabilitation as Medicine
Advocacy Action Center: Urge Your Senator to Protect the Americans with Disabilities Act (ADA) of 1990
What's New Related to Drugs
NEW Course - Navigating the Opioid Crisis: Perils, Pitfalls, and Practical Solutions Course
Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Methylprednisolone Sodium Succinate for Injection, USP, 40mg, 125mg, and 1g Due to High Out of Specification Impurity Results
PM&R Expertise in Stroke Care Exhibited in JAMA
Clarity of Purpose: FDA-Approved mTBI Blood Test
Advocacy Action Center: BCBS of Michigan: Hyaluronan Injections No Longer Payable (Effective 4/1/18)
Hydromorphone HCL Injection USP by Hospira: Recall - Potential For Empty Or Cracked Glass Vials
The 2018 Winter Paralympic Games Starts Friday!